- Prescription of Physical Activity in Individuals with MS: Case Study2023 | First Faculty of Medicine
- Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5)2015 | First Faculty of Medicine
- Profile of a patient with secondary progressive MS - how to identify patients that should be sent to a tertiary Center2021 | Second Faculty of Medicine
- Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome2012 | First Faculty of Medicine
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis2014 | First Faculty of Medicine
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension2018 | First Faculty of Medicine
- Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis2023 | First Faculty of Medicine
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 months2022 | First Faculty of Medicine
- Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry2021 | First Faculty of Medicine
- Prognostic value of single-subject grey matter networks in early multiple sclerosis2024 | First Faculty of Medicine
- Eye-tracking control of an adjustable electric bed: construction and validation by immobile patients with multiple sclerosis2023 | Faculty of Medicine in Hradec Králové
- Experience of hormonal therapy for patients with multiple sclerosis2007 | First Faculty of Medicine
- Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial2013 | First Faculty of Medicine
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- Clinical-radiological paradox in multiple sclerosis - the role of the spinal cord examination2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Neuromyelitis Optica Spectrum Disorders - Retrospective Analysis of Clinical and Paraclinical Findings2015 | First Faculty of Medicine
- A comparison of efficacy of subcutaneous interferon beta-1a 44 mu g, dimethyl fumarate and fingolimod in the real-life clinical practise - a multicenter observational study2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comparison of the effect of teriparatide and risedronate on bone loss in postmenopausal women with multiple sclerosis treated with low-dose glucocorticoids2015 | First Faculty of Medicine
- GALA trial - glatiramer acetate 40 mg three times a week2014 | First Faculty of Medicine
- Assessment of Life Satisfaction in Patients with Clinically Isolated Syndrome2017 | Second Faculty of Medicine
- Reduced bone mineral density in women with multiple sclerosis2013 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Long-Term Treatment with Intrathecal Baclofen in a Multiple Sclerosis Patient - a Case Report2013 | Third Faculty of Medicine
- Effect of subcutaneously administered interferon β-1a on disease activity in patients with clinically isolated syndrome - ATRACT observational study2019 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- The influence on long-term progression of multiple sclerosis - brighter days ahead? The influence on long-term progression of multiple sclerosis - brighter days ahead?2021 | First Faculty of Medicine
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking2009 | First Faculty of Medicine
- AMETYST - Observational Phase IV Study Following the Influence of Intramuscularly Administered Interferon Beta-1a in Patients with Clinically Isolated Syndrome/Clinically Definite Multiple Sclerosis2014 | First Faculty of Medicine
- Possible Application of Pilates Exercise in Multiple Sclerosis Patients2019 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Fingolimod in Real Clinical Practice2017 | First Faculty of Medicine
